About Imaver

Imaver: Empowering Lives Affected by Chronic Myeloid Leukemia

Imaver is a breakthrough oncology drug specifically designed to treat adult and pediatric patients diagnosed with chronic myeloid leukemia (CML) carrying the Philadelphia chromosome mutation (Ph+). With its targeted mechanism of action, Imaver aims to disrupt the growth of cancer cells, offering new hope for patients and their families.


Who Should Avoid Taking IMAVER

Safety Information

Please see full Prescribing Information, which includes a more complete discussion of the risks associated with IMAVER.


  1. Gleevec [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2020.
  2. Pubmed. Available at: Accessed April 19, 2021.
  3. Available at Accessed April 19, 2021.
  4. Data on file. Gleevec Packs Distributed May 2001 - Sept 2020.